~~<i id='E5FA3B933A'><strike id='E5FA3B933A'><tt id='E5FA3B933A'><pre id='E5FA3B933A'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

knowledge

explore

author：entertainment 2025-08-19 12:10:20 - browse：736

The Food and Drug Administration on Thursday approved a gene therapy to treat people with hemophilia A, an inherited and rare bleeding disorder.

The treatment, called Roctavian, is made by BioMarin Pharmaceutical. It was first approved in Europe in August 2022.

Roctavian is a one-time therapy that, in clinical trials, dramatically reduced bleeding episodes and helped patients live without the blood transfusions used to treat the disease. The FDA first rejected Roctavian in 2020, asking BioMarin to amass more data on its safety and long-term durability, and then delayed its decision again to account for additional evidence.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： H5N1 virus can be tracked in retail milk, scientists say

hotspot

explore

focus

entertainment

focus

PacketsofbuprenorphineEliseAmendola/APDoctorsarereportingatroublingtrendwhenitcomestofentanyl.Thepow

WSS

Michigan AG announces felony charges against 'fake electors' in 2020 election plot

Woman gored by Bison at Yellowstone

Biogen joins immunology wave with $1.15 billion acquisition of HI

Congress: Eradicate hepatitis C and reduce the deficit

Cytokinetics CEO Robert Blum is on my Worst CEO shortlist again

Blood tests recalled over risk of missed heart attack diagnosis

knowledge

explore

hotspot

Activists slam private health insurers over coverage restrictions

UnitedHealth argues against case alleging wrongful AI care denials

Apple is now the first public company to be valued at $3 trillion

4 killed in mass shooting in Georgia, shooter remains on the loose: Police

In age of alternative facts, a scholarly course on calling out crap

Europe sees delivery challenges ahead on Alzheimer's therapies

Walensky prepares to leave CDC — and Congress — behind

Federal judge rules Oregon’s tough new gun law is constitutional

State Dept. review finds Biden bears some blame for Afghanistan failures

Federal judge rules Oregon’s tough new gun law is constitutional

explore

As a primary care physician, here's how I hope to partner with AI

Michigan AG announces felony charges against 'fake electors' in 2020 election plot

Study finds gene variants tied to breast cancer risk in Black women

As a primary care physician, here's how I hope to partner with AI

Europe sees delivery challenges ahead on Alzheimer's therapies

Federal judge rules Oregon’s tough new gun law is constitutional

focus

entertainment

entertainment

focus